Top

Published in:

Open Access 01-04-2023 | Correction

Correction to: BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis

Authors: Manal T. Usmani, Robert P. Krattli Jr., Sanad M. El-Khatib, Anh C. D. Le, Sarah M. Smith, Janet E. Baulch, Ding Quan Ng, Munjal M. Acharya, Alexandre Chan

Published in: Neurotherapeutics | Issue 3/2023

Excerpt

Correction to: Neurotherapeutics https://doi.org/10.1007/s13311-022-01339-z …

Title: Correction to: BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis
Authors: Manal T. Usmani
Robert P. Krattli Jr.
Sanad M. El-Khatib
Anh C. D. Le
Sarah M. Smith
Janet E. Baulch
Ding Quan Ng
Munjal M. Acharya
Alexandre Chan
Publication date: 01-04-2023
Publisher: Springer International Publishing
Published in: Neurotherapeutics / Issue 3/2023
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI: https://doi.org/10.1007/s13311-023-01381-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correction to: BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2023

Secondary Ischemic Stroke Prevention

Big Data in Stroke: How to Use Big Data to Make the Next Management Decision

Evolving Stroke Systems of Care: Stroke Diagnosis and Treatment in the Post-Thrombectomy Era

Seizure Rescue Therapies: Comparing Approved and Commonly Used Benzodiazepine Formulations

The Vessel Has Been Recanalized: Now What?

Nonpharmacological Treatments for Hospitalized Patients with Stroke: A Nuanced Approach to Prescribing Early Activity